Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,235 | 76 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $622.49 | 22 | $0 (2024) |
| Shionogi Inc | $257.84 | 5 | $0 (2024) |
| Melinta Therapeutics, LLC | $249.98 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $217.76 | 12 | $0 (2024) |
| Abbott Laboratories | $140.76 | 1 | $0 (2024) |
| PFIZER INC. | $130.88 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $124.88 | 5 | $0 (2024) |
| Boston Scientific Corporation | $123.51 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $113.39 | 5 | $0 (2018) |
| Astellas Pharma US Inc | $54.18 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $985.05 | 29 | Janssen Pharmaceuticals, Inc ($246.28) |
| 2023 | $770.24 | 31 | Janssen Pharmaceuticals, Inc ($277.15) |
| 2022 | $243.30 | 10 | Janssen Pharmaceuticals, Inc ($99.06) |
| 2018 | $236.90 | 6 | Boston Scientific Corporation ($123.51) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: VACCINE | ||||||
| 11/24/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ANTIFUNGALS | ||||||
| 10/02/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $140.76 | General |
| Category: Vascular | ||||||
| 09/25/2024 | Fisher Scientific Company L.L.C. | Procalcitonin (Device) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Infectious Disease | ||||||
| 09/23/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: ANTIFUNGALS | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: VACCINE | ||||||
| 08/08/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: ANTIFUNGALS | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.59 | General |
| 07/18/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/26/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: ANTIFUNGALS | ||||||
| 06/26/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiology | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.74 | General |
| 04/17/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Biological | ||||||
| 04/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,073 | 1,830 | $539,101 | $143,721 |
| 2022 | 12 | 858 | 1,441 | $398,505 | $106,413 |
| 2021 | 8 | 312 | 507 | $150,409 | $45,084 |
| 2020 | 4 | 393 | 777 | $370,997 | $77,372 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 492 | 1,167 | $318,385 | $83,330 | 26.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 236 | 245 | $96,471 | $25,628 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 80 | 80 | $36,234 | $9,040 | 24.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 91 | 92 | $27,189 | $7,175 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 69 | $15,260 | $7,109 | 46.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $21,474 | $4,786 | 22.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 41 | $11,723 | $2,791 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 39 | $7,800 | $2,476 | 31.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 15 | $2,595 | $697.20 | 26.9% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 14 | 14 | $1,400 | $377.96 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 38 | $570.00 | $311.04 | 54.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 361 | 819 | $218,211 | $54,395 | 24.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 124 | 124 | $65,092 | $15,790 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 129 | $19,860 | $9,279 | 46.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 120 | 121 | $32,708 | $8,130 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 52 | $8,290 | $4,374 | 52.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $19,425 | $4,108 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $5,250 | $3,253 | 62.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 30 | $13,691 | $2,862 | 20.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 24 | 24 | $8,870 | $2,352 | 26.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 13 | $3,198 | $871.13 | 27.2% |
| 92552 | Test for hearing various pitches using earphone | Office | 2022 | 31 | 31 | $3,100 | $840.62 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 36 | 54 | $810.00 | $159.34 | 19.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 130 | 213 | $97,980 | $20,682 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 133 | $20,550 | $14,006 | 68.2% |
About Dr. Samuel Ani, MD
Dr. Samuel Ani, MD is a Family Medicine healthcare provider based in Bay Shore, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2009. The National Provider Identifier (NPI) number assigned to this provider is 1417199605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Ani, MD has received a total of $2,235 in payments from pharmaceutical and medical device companies, with $985.05 received in 2024. These payments were reported across 76 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,235).
As a Medicare-enrolled provider, Ani has provided services to 2,636 Medicare beneficiaries, totaling 4,555 services with total Medicare billing of $372,590. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Bay Shore, NY
- Active Since 04/02/2009
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1417199605
Products in Payments
- XARELTO (Drug) $622.49
- Fetroja (Drug) $257.84
- DIFICID (Drug) $170.50
- Rezzayo (Drug) $158.58
- OPTIS (Device) $140.76
- WATCHMAN (Device) $123.51
- ENTRESTO (Drug) $113.39
- Kimyrsa (Drug) $91.40
- ELIQUIS (Drug) $72.35
- Veozah (Drug) $54.18
- IGALMI (Drug) $52.46
- GARDASIL (Biological) $47.26
- XERAVA (Drug) $41.83
- PAXLOVID (Drug) $31.10
- PREVNAR 20 (Biological) $27.43
- VOQUEZNA (Drug) $26.63
- Miro3D (Device) $23.46
- Procalcitonin (Device) $21.29
- Repatha (Biological) $20.18
- CALDOLOR (Drug) $13.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bay Shore
Dr. Louis Loiodice, Do, DO
Family Medicine — Payments: $35,044
Mrs. Carla Canavire Weber, Do, DO
Family Medicine — Payments: $20,707
Dr. Martha Pilchman, M.d, M.D
Family Medicine — Payments: $13,318
Simone Guest, D.o, D.O
Family Medicine — Payments: $13,073
Erika Hiby, M.d, M.D
Family Medicine — Payments: $3,913
Mr. Jose Rodriguez-Ospina, Md, MD
Family Medicine — Payments: $3,867